Overview

To Evaluate the Therapeutic Equivalence and Safety of Azelaic Acid 15% Topical Gel

Status:
Completed
Trial end date:
2017-04-01
Target enrollment:
Participant gender:
Summary
A Multi-Center, Double-Blind, Randomized, Placebo Controlled, Parallel-Group Study
Phase:
Phase 1
Details
Lead Sponsor:
Taro Pharmaceuticals USA
Treatments:
Azelaic acid